Kawasaki disease risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Kawasaki disease}} {{CMG}}; {{AE}} ==Overview== There are no established risk factors for [disease name]. OR The most potent risk factor in the development of...") |
No edit summary |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Kawasaki disease}} | {{Kawasaki disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SH}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of Kawasaki disease are a combination of non-modifiable and modifiable risk factors, that include environmental, [[genetic]], and [[viral]] factors. | |||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of Kawasaki disease are a combination of non-modifiable and modifiable risk factors, that include environmental, [[genetic]], and [[viral]] factors.<ref name="Sánchez-ManubensBou2014">{{cite journal|last1=Sánchez-Manubens|first1=Judith|last2=Bou|first2=Rosa|last3=Anton|first3=Jordi|title=Diagnosis and classification of Kawasaki disease|journal=Journal of Autoimmunity|volume=48-49|year=2014|pages=113–117|issn=08968411|doi=10.1016/j.jaut.2014.01.010}}</ref><ref name="McCrindleRowley20172">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref> | |||
=== | |||
=== | |||
==References== | ==References== | ||
| Line 42: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Pediatrics]] | ||
[[Category:Cardiovascular diseases]] | |||
[[Category:Angiology]] | |||
[[Category:Cardiology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Dermatology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 16:24, 14 February 2020
|
Kawasaki disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
American Roentgen Ray Society Images of Kawasaki disease risk factors |
|
Risk calculators and risk factors for Kawasaki disease risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
Common risk factors in the development of Kawasaki disease are a combination of non-modifiable and modifiable risk factors, that include environmental, genetic, and viral factors.
Risk Factors
Common risk factors in the development of Kawasaki disease are a combination of non-modifiable and modifiable risk factors, that include environmental, genetic, and viral factors.[1][2]
References
- ↑ Sánchez-Manubens, Judith; Bou, Rosa; Anton, Jordi (2014). "Diagnosis and classification of Kawasaki disease". Journal of Autoimmunity. 48-49: 113–117. doi:10.1016/j.jaut.2014.01.010. ISSN 0896-8411.
- ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.